author-photo

Marco Aurelio Salvino

Federal University of Bahia

27

Papers

3

Citations

Citation Trend

Filter By

Papers (16) Sort By

Journal Conference Others

GUIDELINES ON CELL THERAPY

2021
Show All
- Source
- Cite
- Save
Citations (0)
Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular Consensus on genetically modified cells. III: anti-CD19 CAR-T cell therapy for patients with non-Hodgkin lymphoma.

2021 Hematology, Transfusion and Cell Therapy
Show All
- Source
- Cite
- Save
Citations (0)
Influence of The SARS-COV-2 Pandemic on Bone Marrow Transplantation Centers And The Protocols Adopted In Brazil Between May And June 2020

2021 Bone Marrow Transplantation
Show All
- Source
- Cite
- Save
Citations (0)
Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular Consensus on genetically modified cells. IV: CAR-T cell therapy for multiple myeloma patients.

2021 Hematology, Transfusion and Cell Therapy
Show All
- Source
- Cite
- Save
Citations (0)
Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular Consensus on genetically modified cells. I: Structuring centers for the multidisciplinary clinical administration and management of CAR-T cell therapy patients.

2021 Hematology, Transfusion and Cell Therapy
Show All
- Source
- Cite
- Save
Citations (1)
Evaluation of Hematopoietic Stem Cell Product As a New Site for Minimal Residual Disease By Next Generation Flow in Multiple Myeloma

2021 Blood
Show All
- Source
- Cite
- Save
Citations (0)
P-173: Impact of Daratumumab (DARA) administration during transplant-eligible newly diagnosed Multiple Myeloma (TE NDMM) induction on stem cell (SC) mobilization count and post-transplant engraftment

2021 Clinical Lymphoma, Myeloma & Leukemia
Show All
- Source
- Cite
- Save
Citations (0)
Preliminary Results of Daratumumab, Cyclophosphamide, Thalidomide and Dexamethasone: A Quadruplet Intensified Treatment for Newly Diagnosed Multiple Myeloma (NDMM) Transplant Eligible (TE) Patients

2020 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Immune Profiling Evaluation of Newly Diagnose Multiple Myeloma (NDMM) Transplant Eligible (TE) Patients Treated with Daratumumab, Cyclophosphamide, Thalidomide and Dexamethasone. Preliminary Results

2020 Blood
Show All
- Source
- Cite
- Save
Citations (0)
10-Year Real-World Data on Acute Myeloid Leukemia: The Paradigm of a Public Health Center in Brazil

2020 Blood
Show All
- Source
- Cite
- Save
Citations (0)